Skip to main content
. 2020 Sep 11;12(9):865. doi: 10.3390/pharmaceutics12090865

Table 2.

Retention time (tR), molecular formulae, observed molecular ions, mass errors, product ions, and biotransformation of DWP16001 and its metabolites identified in mouse, rat, dog, monkey, and human hepatocytes.

Compound tR (min) Elemental Composition Observed [M+NH4]+ (m/z) Mass Error (ppm) Product Ions (m/z) Biotransformation
DWP16001 9.4 C24H31O6NCl 464.1829 −1.08 327.1140, 311.0675, 209.0361, 131.0854
M1 8.8 C24H31O7NCl 480.1781 −0.62 427.1303, 409.1196, 325.0985, 309.0519, 207.0205, 131.0855 Monohydroxylation
M2 8.0 C24H31O7NCl 480.1793 1.87 445.1405, 427.1301, 409.1193, 343.1093, 209.0361, 147.0803 Monohydroxylation
M3 8.4 C24H31O8NCl 496.1727 −1.21 479.1462, 443.1249, 425.1142, 383.1048, 341.0931, 131.0854 Hydroxylation + oxidation
M4 7.4 C24H31O8NCl 496.1723 −2.02 479.1468, 443.1257, 425.1151, 407.1046, 207.0208, 147.0804 Dihydroxylation
M5 8.0 C24H31O8NCl 496.1728 -1.01 479.1471, 443.1261, 425.0962, 359.1047, 163.0751 Dihydroxylation
U1 8.1 C30H39O12NCl 640.2161 0.94 464.1826, 327.1149, 311.0678, 131.0856 Glucuronidation
U2 9.1 C30H39O12NCl 640.2145 −1.56 447.1571, 327.1149, 311.0680, 131.0857 Glucuronidation
U3 8.6 C30H39O12NCl 640.2150 −0.78 464.1833, 447.1566, 327.1143, 311.0678, 131.0854 Glucuronidation
U4 8.1 C30H39O13NCl 656.2099 −0.76 463.1516, 445.1410, 325.0987, 309.0522, 207.0205, 131.0855 Hydroxylation + glucuronidation
U5 8.6 C30H39O13NCl 656.2099 −0.76 445.1397, 325.0987, 309.0522, 207.0206, 131.0855 Hydroxylation + glucuronidation